• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Atherosclerosis is the build-up of fatty deposits in the arteries. Atherosclerosis is the main
underlying cause of cardiovascular diseases and the leading cause of global morbidity and …

Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

Since the 2009 publication of the stress echocardiography expert consensus of the
European Association of Echocardiography, and after the 2016 advice of the American …

The detection and characterization of coronary artery stenosis and atherosclerosis using
imaging tools are key for clinical decision-making in patients with known or suspected …

Ischemic heart disease is the greatest health burden and most frequent cause of death
worldwide. Myocardial ischemia/reperfusion is the pathophysiological substrate of ischemic …

Importance In the Revascularization for Ischemic Ventricular Dysfunction (REVIVED-BCIS2)
trial, percutaneous coronary intervention (PCI) did not improve outcomes for patients with …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Background Myocardial revascularization has been advocated to improve myocardial
function and prognosis in ischemic cardiomyopathy (ICM). We discuss the evidence for …

BACKGROUND: Coronary artery bypass grafting (CABG) is the recommended mode of
revascularization in patients with ischemic left ventricular dysfunction (iLVSD) and …